Catalyst Biosciences, Inc. - Special Call Transcript
Greetings, and welcome to the Catalyst Biosciences Conference Call. (Operator Instructions)
As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Ana Kapor, Investor Relations at Catalyst Biosciences. Thank you. You may begin.
Thank you, and welcome to our update call. This morning at the EAHAD 2020 meeting in The Hague, data from our Phase IIb trial for DalcA in patients with severe hemophilia B was presented in an oral session. Data from our MarzAA and Factor IX gene therapy programs were also presented in three posters. Our call today is to review the data presented and answer any questions. Joining me today from Catalyst are Dr. Nassim Usman, President and Chief Executive Officer; Dr. Howard Levy, Chief Medical Officer; and Grant Blouse, Vice President, Translational Research.
Before we begin, I would like to remind you that various remarks that we make on this call contain forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
